MENU

Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments

Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story